UBS Group’s 9 Meters Biopharma, Inc. Common Stock NMTR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-4,340
| Closed | -$6.03K | – | 8930 |
|
2023
Q1 | $6.03K | Sell |
4,340
-7,989
| -65% | -$11.1K | ﹤0.01% | 6870 |
|
2022
Q4 | $15.5K | Buy |
12,329
+6,584
| +115% | +$8.3K | ﹤0.01% | 6785 |
|
2022
Q3 | $25K | Sell |
5,745
-1
| -0% | -$4 | ﹤0.01% | 6035 |
|
2022
Q2 | $30K | Buy |
5,746
+4,314
| +301% | +$22.5K | ﹤0.01% | 5381 |
|
2022
Q1 | $17K | Sell |
1,432
-4,456
| -76% | -$52.9K | ﹤0.01% | 6654 |
|
2021
Q4 | $116K | Buy |
5,888
+2,733
| +87% | +$53.8K | ﹤0.01% | 5115 |
|
2021
Q3 | $82K | Buy |
3,155
+240
| +8% | +$6.24K | ﹤0.01% | 4890 |
|
2021
Q2 | $64K | Buy |
2,915
+1,139
| +64% | +$25K | ﹤0.01% | 5161 |
|
2021
Q1 | $42K | Sell |
1,776
-1,978
| -53% | -$46.8K | ﹤0.01% | 5723 |
|
2020
Q4 | $64K | Buy |
3,754
+3,694
| +6,157% | +$63K | ﹤0.01% | 4982 |
|
2020
Q3 | $1K | Buy |
+60
| New | +$1K | ﹤0.01% | 6987 |
|
2020
Q2 | – | Sell |
-85
| Closed | -$1K | – | 7416 |
|
2020
Q1 | $1K | Sell |
85
-425
| -83% | -$5K | ﹤0.01% | 6912 |
|
2019
Q4 | $6K | Buy |
+510
| New | +$6K | ﹤0.01% | 6470 |
|
2019
Q3 | – | Sell |
-3
| Closed | – | – | 7242 |
|
2019
Q2 | $0 | Buy |
+3
| New | – | ﹤0.01% | 7219 |
|
2019
Q1 | – | Sell |
-690
| Closed | -$32K | – | 7223 |
|
2018
Q4 | $32K | Buy |
690
+640
| +1,280% | +$29.7K | ﹤0.01% | 5540 |
|
2018
Q3 | $7K | Sell |
50
-331
| -87% | -$46.3K | ﹤0.01% | 6433 |
|
2018
Q2 | $179K | Buy |
+381
| New | +$179K | ﹤0.01% | 4183 |
|
2018
Q1 | – | Sell |
-68
| Closed | -$8K | – | 7136 |
|
2017
Q4 | $8K | Buy |
68
+12
| +21% | +$1.41K | ﹤0.01% | 6201 |
|
2017
Q3 | $8K | Buy |
56
+10
| +22% | +$1.43K | ﹤0.01% | 6098 |
|
2017
Q2 | $4K | Buy |
+46
| New | +$4K | ﹤0.01% | 6282 |
|
2017
Q1 | – | Sell |
-10
| Closed | -$3K | – | 6900 |
|
2016
Q4 | $3K | Buy |
+10
| New | +$3K | ﹤0.01% | 6454 |
|